What question did this study set out to answer?

To outline the mechanistic links between central obesity and the onset of cardiorenal metabolic diseases and identify strategies to reduce this health burden.

January 1, 2024Cardiorenal MedicineOpen Access

Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases

View Full Paper

Ask AI

Bookmark

To outline the mechanistic links between central obesity and the onset of cardiorenal metabolic diseases and identify strategies to reduce this health burden.
Review and synthesis of evidence connecting abdominal adiposity with cardiorenal and metabolic dysfunctions.
Assessment of population-based interventions, including dietary, lifestyle, and pharmacological management.
Central obesity functions as a pivotal mechanistic driver in the pathogenesis of cardiorenal metabolic diseases.
Effective risk reduction requires dual approaches combining population-level lifestyle modifications with targeted pharmacotherapies.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Review highlights the central role of central obesity in cardiorenal metabolic diseases, indicating the need for targeted lifestyle and pharmacological interventions.

Cite This Study

Al‐Chalabi et al. (2024) studied this question.

synapsesocial.com/papers/69dbc82250e1971baba3cb4a https://doi.org/10.1159/000535772

View Full Paper

Ask AI

Bookmark

Implication

Review highlights the central role of central obesity in cardiorenal metabolic diseases, indicating the need for targeted lifestyle and pharmacological interventions.

Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases

Key Points

Discussion

Implication

Cite This Study

Mechanistic Links between Central Obesity and Cardiorenal Metabolic Diseases

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider